Dymind attended the 71st AACC at Anaheim Convention Center, Anaheim, CA, U.S. from August 6th-8th. AACC is the largest global scientific conference and trade show in the field of laboratory medicine. At this dynamic meeting, visitors had an opportunity to explore the wide range of laboratory innovations in the field of hematology, clinical chemistry, chemiluminescence immunology, and others.
At this year, what's new and what' s to be expected at Dymind booth#3175? Please follow my steps…Here's a short video showing how Dymind was making the speech at AACC on August 6th.
"The medium and small labs share similar requirements for hematology analyzer, which include full 5-part WBC differentiation as well as suitable capacity agree with limited space and budget. For that, it's important to know more about the prospect of mini 5-part hematology analyzer." said Rocky Shi, International Marketing Manager of Dymind, at our corporate satellite.
In the morning of August 6th , Rocky shared the clinical significance of 5-part differentiation and introduced our DF52, mini 5-part hematology analyzer.
“As we all know, infectious diseases are the most common clinical diseases. For now, rational drug use has been accepted a global clinical consensus for treating infection. And CRP is one of well-known infection indicators. As a professional IVD solution innovator, we have the DF50CRP, a mini 5-part hematology + CRP analyzer, which has been first launched in the world. In the near future, we will launch our DH76CRP, with automatic capillary blood sampling.”